6Younger D S, Rakasadawan N. Medical therapies in myasthenia gravis [J]. Chest Surg Clln N Am, 2001,11 (2) : 329-333.
7Katz J, Barohn R J. Update on the evaluation and therapy of autoimmune neuromuscular junction disorders[J]. Phys Med Rehabil Clin N Am,2001,12(2) :381-397.
8Tzartos S J, Remoundos M, Delson C J, et al. Helper T Ceils in antibody-mediated, organ-speetie autoimmunity [ J ]. Curr Opin Immunol, 2000,12(6) :664-669.
9Goldstein G, Alan R, Liss I. Overview of immunoregulation by thymopoietin[ A]. Immune regulation by characterizded polypeptides. NY, 1987 : 51-59.
10Wang Jing, Lu Wanliang, Liang Gongwen, et al. Pharmacokineties, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers[J].Peptides,2006,27(4):826-835.
